Clinical Trials Browser

Phase 2/3 × Completed × Hematologic Neoplasms × Clear all

Graft vs Host Disease, Recurrence, Hematologic Neoplasms

NCT03483194 2020-06-23

REVEH

Phase 2/3 Completed

126 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00469729 2015-07-10

ExCell

Phase 2/3 Completed

101 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00165282 2013-11-28

Mindfulness Meditation in Bone Marrow Transplantation

Phase 2/3 Completed

241 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00557817 2010-01-11

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Phase 2/3 Completed

125 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00382759 2009-08-03

Nonmyeloablative Stem Cell Transplant in Elderly

Phase 2/3 Completed

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

Clinical Trials

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

REVEH

ExCell

Mindfulness Meditation in Bone Marrow Transplantation

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Nonmyeloablative Stem Cell Transplant in Elderly